Biogen Acquires Human Immunology Biosciences for $1.8 Billion to Bolster Pipeline in Immune-Mediated Diseases

Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-m...

May 23, 2024 | Thursday | News
Genmab Completes $1.8 Billion Acquisition of ProfoundBio, Secures Rights to Promising Cancer Treatments

Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash Acquisition gives Genmab worldwide rights to three candidates in clini...

May 22, 2024 | Wednesday | News
YGION Biomedical Secures €15M in Series A Funding to Advance Personalized Cancer Vaccine Technology

YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the completion of a Series A fina...

May 21, 2024 | Tuesday | News
Sanofi, Formation Bio, and OpenAI Forge Pioneering Partnership to Transform Drug Development with AI

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more eff...

May 21, 2024 | Tuesday | News
ARS Pharmaceuticals Advances neffy® MAA with CHMP Response, Inks CSL Seqirus Deal for Australia & New Zealand

CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by...

May 01, 2024 | Wednesday | News
Cidara Therapeutics Strikes $128 Million Deal to Divest rezafungin, Bolstering Focus on Cloudbreak Development

  Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical de...

April 25, 2024 | Thursday | News
Exergen Corporation Takes Legal Action to Protect Rights in Face of Baxter International's Censorship Attempt

Exergen Corporation, a leader in temperature measurement technology, has filed a lawsuit against Baxter International Inc. in the United States District Co...

April 24, 2024 | Wednesday | News
Bio-Rad to Invest in Oncocyte for Exclusive Global Transplant Monitoring Technology, Eyeing FDA Clearance and Market Expansion

Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-R...

April 12, 2024 | Friday | News
Blue Wolf Capital Partners to Acquire Seven European Manufacturing and Development Facilities from Recipharm

    The facilities, located in Solna, Stängnäs, Höganäs, Karlskoga, and Uppsala OTC Development in Sweden, Pessac in France...

April 03, 2024 | Wednesday | News
Genmab to Acquire ProfoundBio for USD 1.8 Billion in Cash

Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have officially announced a definitive agreement for Genmab's acquisition of ProfoundBio in an all-cash dea...

April 03, 2024 | Wednesday | News
Gilead Sciences Completes Acquisition of CymaBay, Strengthening Liver Disease Therapies

    “The acquisition of CymaBay brings us a potential best-in-disease therapy that could transform the treatment landscape for people wit...

March 25, 2024 | Monday | News
XRP Healthcare Collaborates with Isansys Lifecare to Transform Healthcare in Uganda

  Isansys Lifecare, led by the visionary Keith Errey, has gained recognition in the global healthcare technology market, particularly through its suc...

March 25, 2024 | Monday | News
Croda International Plc and AAHI Partner to Advance Global Access to Next-Generation Vaccine Adjuvants

Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce the signing of a partnership agreement around in...

March 21, 2024 | Thursday | News
Lonza Strikes Deal with Roche: Acquires Genentech Facility in Vacaville for $1.2 Billion to Bolster Biologics Manufacturing Capacity

Lonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 billion in cash Vacaville (US) si...

March 20, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close